PerpEquities

Equity

AbCellera Biologics Inc. (ABCL) perpetual futures

AbCellera Biologics Inc. is a Vancouver-based biotech company (founded 2012) that uses an AI-driven platform to discover antibodies for drug development, collaborating with partners such as Eli Lilly.

+0.7%NASDAQ closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:ABCL

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/1 live markets
Venues
1
Live markets
0/1
24h volume
$0
Open interest
$0
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D+0.71%
5D-7.72%
1M+94.85%
6M+206.20%
YTD+232.16%
1Y+184.71%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeABCL-USDTPlanned------USDT-

Embed this asset

ABCL perpetuals · perpequities.comABCL perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/abcl-perp"><img src="https://perpequities.com/badge/abcl-perp.svg" width="240" height="64" alt="ABCL perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 1h ago
Market cap
$3.5B
Updated 1h ago
Revenue
$66.2M
Trailing 12 months
Revenue growth
-67%
Next fiscal year
Profit margin
-248.8%
P/E
-21.0
Peer P/E -8.5
Free cash flow
-$179.5M
Trailing 12 months
More metrics
Net income
-$164.7M
Trailing 12 months
P/S
52.4
Peer P/E
-8.5
Similar listed perps
Revenue estimate
$25.2M
Next fiscal year
Earnings
2026-11-05
Revenue est. $5.3M · Updated 1h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$75.1M
Net margin-194.9%
Free cash flow-$174.1M
Net debt$14.7M
2020$233.2M
2021$375.2M
2022$485.4M
2023$38M
2024$28.8M
2025$75.1M
PeriodRevenueGrowthNet incomeFCF
2020$233.2M+1,908%$118.9M$8M
2021$375.2M+61%$153.5M$186.1M
2022$485.4M+29%$158.5M$204.7M
2023$38M-92%-$146.4M-$121.4M
2024$28.8M-24%-$162.9M-$187M
2025$75.1M+161%-$146.4M-$174.1M
PeriodGross marginOperating marginNet marginROEROA
2020+88.4%+66.9%+51.0%+14.3%+11.8%
2021+87.9%+54.5%+40.9%+15.0%+11.6%
2022+86.3%+44.6%+32.7%+12.9%+10.3%
2023+100.0%-623.8%-385.0%-12.7%-9.8%
2024+100.0%-1,091.7%-564.8%-15.4%-12.0%
2025+61.6%-289.0%-194.9%-15.1%-10.8%
PeriodCashDebtNet debtCurrent ratio
2020$594.1M$6.8M-$587.3M7.86
2021$476.1M$40.1M-$436.1M7.70
2022$386.5M$82.3M-$304.3M8.67
2023$133.3M$77.4M-$55.9M7.33
2024$156.3M$65.4M-$91M9.81
2025$128.5M$143.2M$14.7M11.32
PeriodMarket capEnterprise valueP/SP/E
2020$10.6B$10B45.489.4
2021$3.9B$3.5B10.525.5
2022$2.9B$2.6B5.918.1
2023$1.7B$1.6B43.4-11.2
2024$862.4M$771.4M29.9-5.3
2025$1B$1B13.6-7.0
Q3 2024$6.5M
Q4 2024$5.1M
Q1 2025$4.2M
Q2 2025$17.1M
Q3 2025$9M
Q4 2025$44.9M
Q1 2026$8.3M
Q2 2026$4.1M
PeriodRevenueGrowthNet incomeFCF
Q3 2024$6.5M-1%-$51.1M-$47.6M
Q4 2024$5.1M-45%-$34.2M-$23.6M
Q1 2025$4.2M-57%-$45.6M-$22.2M
Q2 2025$17.1M+133%-$34.7M-$45.8M
Q3 2025$9M+38%-$57.1M-$61.5M
Q4 2025$44.9M+788%-$8.9M-$44.6M
Q1 2026$8.3M+96%-$43.2M-$37.4M
Q2 2026$4.1M-76%-$55.4M-$36M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+100.0%-1,439.4%-785.4%-4.7%-3.7%
Q4 2024+100.0%-1,440.7%-677.4%-3.2%-2.5%
Q1 2025+100.0%-1,479.6%-1,077.2%-4.5%-3.4%
Q2 2025+100.0%-290.2%-203.3%-3.4%-2.5%
Q3 2025+100.0%-851.8%-637.8%-5.9%-4.2%
Q4 2025+82.3%-63.7%-19.9%-0.9%-0.7%
Q1 2026-4.1%-691.7%-519.1%-4.6%-3.3%
Q2 2026+100.0%-1,550.0%-1,368.6%-6.2%-4.2%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$126.6M$71.4M-$55.2M9.34
Q4 2024$156.3M$65.4M-$91M9.81
Q1 2025$159.3M$67.8M-$91.4M10.15
Q2 2025$92.4M$142.1M$49.6M11.07
Q3 2025$83.2M$142.2M$59.1M10.10
Q4 2025$128.5M$143.2M$14.7M11.32
Q1 2026$77.1M$140.2M$63.1M14.05
Q2 2026$120.1M$135.6M$15.6M12.77
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$766.6M$711.4M117.8-3.8
Q4 2024$863.1M$772.2M170.9-6.1
Q1 2025$663.9M$572.4M156.8-3.7
Q2 2025$1B$1.1B59.9-7.1
Q3 2025$1.5B$1.6B167.9-6.6
Q4 2025$1B$1B22.8-28.5
Q1 2026$1.1B$1.1B127.2-6.2
Q2 2026$2.4B$2.4B592.3-10.9
Historical value series
Revenue
Q3 2023: $6.6MQ4 2023: $9.2MQ1 2024: $10MQ2 2024: $7.3MQ3 2024: $6.5MQ4 2024: $5.1MQ1 2025: $4.2MQ2 2025: $17.1MQ3 2025: $9MQ4 2025: $44.9MQ1 2026: $8.3MQ2 2026: $4.1MQ3 2023Q2 2026
Net income
Q3 2023: -$28.6MQ4 2023: -$47.2MQ1 2024: -$40.6MQ2 2024: -$36.9MQ3 2024: -$51.1MQ4 2024: -$34.2MQ1 2025: -$45.6MQ2 2025: -$34.7MQ3 2025: -$57.1MQ4 2025: -$8.9MQ1 2026: -$43.2MQ2 2026: -$55.4MQ3 2023Q2 2026
EBITDA
Q3 2023: -$44.7MQ4 2023: -$53.6MQ1 2024: -$44.9MQ2 2024: -$52.1MQ3 2024: -$51.9MQ4 2024: -$55.3MQ1 2025: -$51.9MQ2 2025: -$38.8MQ3 2025: -$66.3MQ4 2025: -$11.6MQ1 2026: -$40.9MQ2 2026: -$41.5MQ3 2023Q2 2026
Free cash flow
Q3 2023: -$20.4MQ4 2023: -$34MQ1 2024: -$65.8MQ2 2024: -$49.3MQ3 2024: -$47.6MQ4 2024: -$23.6MQ1 2025: -$22.2MQ2 2025: -$45.8MQ3 2025: -$61.5MQ4 2025: -$44.6MQ1 2026: -$37.4MQ2 2026: -$36MQ3 2023Q2 2026
EPS
Q3 2023: -$0.1Q4 2023: -$0.16Q1 2024: -$0.14Q2 2024: -$0.13Q3 2024: -$0.17Q4 2024: -$0.12Q1 2025: -$0.15Q2 2025: -$0.12Q3 2025: -$0.19Q4 2025: -$0.03Q1 2026: -$0.14Q2 2026: -$0.18Q3 2023Q2 2026
Cash / Debt
Q3 2023 · Cash: $172.4MQ3 2023 · Debt: $80.8MQ4 2023 · Cash: $133.3MQ4 2023 · Debt: $77.4MQ1 2024 · Cash: $123.6MQ1 2024 · Debt: $73.6MQ2 2024 · Cash: $148.3MQ2 2024 · Debt: $72.1MQ3 2024 · Cash: $126.6MQ3 2024 · Debt: $71.4MQ4 2024 · Cash: $156.3MQ4 2024 · Debt: $65.4MQ1 2025 · Cash: $159.3MQ1 2025 · Debt: $67.8MQ2 2025 · Cash: $92.4MQ2 2025 · Debt: $142.1MQ3 2025 · Cash: $83.2MQ3 2025 · Debt: $142.2MQ4 2025 · Cash: $128.5MQ4 2025 · Debt: $143.2MQ1 2026 · Cash: $77.1MQ1 2026 · Debt: $140.2MQ2 2026 · Cash: $120.1MQ2 2026 · Debt: $135.6MQ3 2023Q2 2026
CashDebt
Profitability
Q3 2023 · Gross margin: +100.0%Q4 2023 · Gross margin: +100.0%Q1 2024 · Gross margin: +100.0%Q2 2024 · Gross margin: +100.0%Q3 2024 · Gross margin: +100.0%Q4 2024 · Gross margin: +100.0%Q1 2025 · Gross margin: +100.0%Q2 2025 · Gross margin: +100.0%Q3 2025 · Gross margin: +100.0%Q4 2025 · Gross margin: +82.3%Q1 2026 · Gross margin: -4.1%Q2 2026 · Gross margin: +100.0%Q3 2023 · Operating margin: -831.8%Q4 2023 · Operating margin: -719.6%Q1 2024 · Operating margin: -551.5%Q2 2024 · Operating margin: -1,276.2%Q3 2024 · Operating margin: -1,439.4%Q4 2024 · Operating margin: -1,440.7%Q1 2025 · Operating margin: -1,479.6%Q2 2025 · Operating margin: -290.2%Q3 2025 · Operating margin: -851.8%Q4 2025 · Operating margin: -63.7%Q1 2026 · Operating margin: -691.7%Q2 2026 · Operating margin: -1,550.0%Q3 2023 · Net margin: -433.6%Q4 2023 · Net margin: -513.7%Q1 2024 · Net margin: -408.0%Q2 2024 · Net margin: -504.3%Q3 2024 · Net margin: -785.4%Q4 2024 · Net margin: -677.4%Q1 2025 · Net margin: -1,077.2%Q2 2025 · Net margin: -203.3%Q3 2025 · Net margin: -637.8%Q4 2025 · Net margin: -19.9%Q1 2026 · Net margin: -519.1%Q2 2026 · Net margin: -1,368.6%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth
Q3 2024: -1.4%Q4 2024: -45.0%Q1 2025: -57.5%Q2 2025: +133.3%Q3 2025: +37.6%Q4 2025: +788.2%Q1 2026: +96.3%Q2 2026: -76.3%Q3 2023Q2 2026
Shares outstanding
Q3 2023: 289.5MQ4 2023: 290.9MQ1 2024: 292.7MQ2 2024: 294.2MQ3 2024: 294.9MQ4 2024: 294.6MQ1 2025: 297.7MQ2 2025: 298.5MQ3 2025: 298.9MQ4 2025: 298.7MQ1 2026: 303.1MQ2 2026: 305.6MQ3 2023Q2 2026
Valuation
Q3 2023 · P/E: -11.5Q4 2023 · P/E: -8.9Q1 2024 · P/E: -7.9Q2 2024 · P/E: -5.3Q3 2024 · P/E: -3.8Q4 2024 · P/E: -6.1Q1 2025 · P/E: -3.7Q2 2025 · P/E: -7.1Q3 2025 · P/E: -6.6Q4 2025 · P/E: -28.5Q1 2026 · P/E: -6.2Q2 2026 · P/E: -10.9Q3 2023 · P/S: 201.8Q4 2023 · P/S: 181.0Q1 2024 · P/S: 130.6Q2 2024 · P/S: 111.7Q3 2024 · P/S: 117.8Q4 2024 · P/S: 170.9Q1 2025 · P/S: 156.8Q2 2025 · P/S: 59.9Q3 2025 · P/S: 167.9Q4 2025 · P/S: 22.8Q1 2026 · P/S: 127.2Q2 2026 · P/S: 592.3Q3 2023Q2 2026
P/EP/S
Revenue
2018: $8.8M2019: $11.6M2020: $233.2M2021: $375.2M2022: $485.4M2023: $38M2024: $28.8M2025: $75.1M20182025
Net income
2018: $309K2019: -$2.2M2020: $118.9M2021: $153.5M2022: $158.5M2023: -$146.4M2024: -$162.9M2025: -$146.4M20182025
EBITDA
2018: $1.4M2019: -$155K2020: $169.6M2021: $239.1M2022: $260.2M2023: -$192.2M2024: -$204.1M2025: -$148.8M20182025
Free cash flow
2018: -$1.7M2019: -$1.3M2020: $8M2021: $186.1M2022: $204.7M2023: -$121.4M2024: -$187M2025: -$174.1M20182025
EPS
2018: $02019: -$0.012020: $0.452021: $0.482022: $0.52023: -$0.512024: -$0.552025: -$0.4920182025
Cash / Debt
2018 · Cash: $10.4M2018 · Debt: $3.4M2019 · Cash: $7.6M2019 · Debt: $6.9M2020 · Cash: $594.1M2020 · Debt: $6.8M2021 · Cash: $476.1M2021 · Debt: $40.1M2022 · Cash: $386.5M2022 · Debt: $82.3M2023 · Cash: $133.3M2023 · Debt: $77.4M2024 · Cash: $156.3M2024 · Debt: $65.4M2025 · Cash: $128.5M2025 · Debt: $143.2M20182025
CashDebt
Profitability
2018 · Gross margin: +100.0%2019 · Gross margin: +100.0%2020 · Gross margin: +88.4%2021 · Gross margin: +87.9%2022 · Gross margin: +86.3%2023 · Gross margin: +100.0%2024 · Gross margin: +100.0%2025 · Gross margin: +61.6%2018 · Operating margin: -8.5%2019 · Operating margin: -35.5%2020 · Operating margin: +66.9%2021 · Operating margin: +54.5%2022 · Operating margin: +44.6%2023 · Operating margin: -623.8%2024 · Operating margin: -1,091.7%2025 · Operating margin: -289.0%2018 · Net margin: +3.5%2019 · Net margin: -19.0%2020 · Net margin: +51.0%2021 · Net margin: +40.9%2022 · Net margin: +32.7%2023 · Net margin: -385.0%2024 · Net margin: -564.8%2025 · Net margin: -194.9%20182025
Gross marginOperating marginNet margin
Revenue growth
2019: +31.5%2020: +1,907.9%2021: +60.9%2022: +29.4%2023: -92.2%2024: -24.2%2025: +160.6%20182025
Shares outstanding
2018: 151M2019: 237.7M2020: 263.1M2021: 318.3M2022: 314.8M2023: 289.2M2024: 294.3M2025: 298.7M20182025
Valuation
2018 · P/E: 29,450.02019 · P/E: -5,718.42020 · P/E: 89.42021 · P/E: 25.52022 · P/E: 18.12023 · P/E: -11.22024 · P/E: -5.32025 · P/E: -7.02018 · P/S: 1,007.42019 · P/S: 1,092.72020 · P/S: 45.42021 · P/S: 10.52022 · P/S: 5.92023 · P/S: 43.42024 · P/S: 29.92025 · P/S: 13.620182025
P/EP/S

Refreshed 1h ago

Next catalyst

Catalysts

Earnings
2026-11-05
Revenue est. $5.3M · Updated 1h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 2026-0.66$25.2M-67%4
FY 2027-0.72$26.1M-65%4
FY 2028-0.85$25M-67%5
FY 2029-0.76$57.6M-23%1
FY 2030-0.64$139.9M+86%1
Q1 2027-0.19$7.8M-6%1

Company events

6
2026-11-05EarningsActual - / Estimate -0.18-
2026-08-05EarningsActual -0.18 / Estimate -0.16Miss
2026-05-11EarningsActual -0.14 / Estimate -0.22Beat
2026-02-24EarningsActual -0.03 / Estimate -0.18Beat
2025-11-06EarningsActual -0.19 / Estimate -0.17Miss
2025-08-07EarningsActual -0.12 / Estimate -0.17Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
FLY$3.5B12.1-8.8-126.6%5UUUU$3.6B33.8-42.7-77.3%1QS$3.4B--8.10.0%1IOVA$3.8B11.8-12.3-89.1%1FRMI$3B--3.40.0%1OPEN$3B0.7-1.6-46.7%1SOUN$3B14.5-20.3-67.5%1MARA$4B5.0-1.1-429.7%14